Prader-Willi syndrome (PWS) is a rare genetic disorder that affects roughly 1 in 15,000 to 30,000 births worldwide. It causes severe low muscle tone and feeding difficulties in infancy, then shifts dramatically in early childhood to an insatiable hunger that can lead to life-threatening obesity if food intake isn’t carefully controlled. The condition also affects growth, cognitive development, and behavior throughout life.
What Causes Prader-Willi Syndrome
PWS happens when certain genes on chromosome 15 that should be active from the father’s side are missing or silent. Normally, everyone inherits two copies of chromosome 15, one from each parent. But in this particular region, only the father’s copy is supposed to be “switched on.” When those paternal genes don’t work, the result is PWS.
This can happen in three ways. In about 70% of cases, a small section of the father’s chromosome 15 is simply deleted. It’s not inherited from the parents but occurs spontaneously. In roughly 25% of cases, the child inherits two copies of chromosome 15 from their mother and none from their father, a situation called maternal uniparental disomy. The remaining cases result from errors in the molecular “switch” (called the imprinting center) that’s supposed to activate the father’s genes, or from rare chromosome rearrangements.
Regardless of the specific mechanism, the outcome is the same: the brain doesn’t receive instructions from a critical set of genes, particularly those that regulate appetite, growth, and metabolism.
Symptoms in Infancy
The earliest sign is severe muscle weakness, or hypotonia. Newborns with PWS feel unusually floppy when held, often described as “rag doll-like.” Their elbows and knees rest loosely extended rather than flexed. This poor muscle tone makes feeding extremely difficult because the sucking reflex is weak. Nearly all infants with PWS, about 99%, have feeding difficulties that require special nipples or nasogastric tube feeding for weeks to months.
During this phase, the challenge is getting babies to gain enough weight, the opposite of what most people associate with the condition. Reduced fetal movement and lower birth weight compared to siblings are also common, sometimes noticeable even before birth.
The Shift to Insatiable Hunger
The transition from poor feeding to excessive appetite doesn’t happen overnight. Research has identified seven distinct nutritional phases that people with PWS typically move through. Around 9 to 25 months, feeding improves and growth normalizes. Then, between ages 2 and 4, weight starts increasing even without a noticeable jump in appetite or calorie intake. By ages 4 to 8, appetite clearly rises, though children can still feel full. The most challenging phase begins around age 8, when true hyperphagia sets in: a relentless, rarely satisfied hunger that persists into adulthood. Some adults eventually reach a phase where appetite becomes somewhat more manageable, though this isn’t universal.
The driving force behind this hunger is a hormone called ghrelin, the “hunger hormone” that your stomach releases when you haven’t eaten. In most people, ghrelin levels drop after a meal. In people with PWS, ghrelin stays persistently elevated even after eating. This has been measured in individuals as young as five weeks old, well before the hyperphagic phase begins. Combined with disrupted signaling in the brain’s appetite-control center, the result is a person who genuinely, physiologically never feels full.
Making matters worse, people with PWS have a lower resting metabolic rate. Infants and children with the condition typically need only 60% to 80% of the calories a person their age would normally require to maintain a healthy weight. So the combination of extreme hunger with a body that burns fewer calories creates a serious risk of rapid, dangerous weight gain.
Physical Features and Growth
PWS produces several recognizable physical characteristics. These include a narrow forehead, almond-shaped eyes, a triangular mouth, short stature, and notably small hands and feet. Not every feature is present in every person, and some become more apparent with age.
Without treatment, short stature is common because the body doesn’t produce enough growth hormone. Growth hormone therapy, typically started in early childhood, helps normalize height, increases lean muscle mass, decreases body fat percentage, and speeds head growth. Studies have also found that growth hormone treatment in young children improves language and cognitive development, making it beneficial well beyond just physical growth.
Behavioral and Emotional Patterns
PWS affects behavior in ways that go beyond food-seeking. Temper tantrums, stubbornness, and mood swings are common and often intensify when food is restricted or routines are disrupted. About 77% of children with PWS become angry when food is withheld, compared to roughly 42% of typically developing children in the same situation.
Compulsive behaviors emerge early. Research shows that compulsive tendencies appear in many children with PWS within their first two years, and about half display them by kindergarten age. These include hoarding, arranging objects, counting, and repetitive speech. Skin picking is particularly prevalent: around one-third of children with PWS pick at their skin to the point of gouging, and by ages 4 to 5, roughly 40% engage in skin picking that can draw blood. This rate is dramatically higher than in other developmental conditions or in typically developing children.
Some researchers believe a neurochemical pattern similar to obsessive-compulsive disorder underlies both the compulsive behaviors and the intense food preoccupation, suggesting they may share a common biological root rather than being separate problems.
How PWS Is Diagnosed
While the physical features and symptom pattern can raise suspicion, a definitive diagnosis requires DNA testing. Clinical features alone overlap too much with other conditions and with typical obesity to be conclusive. A type of DNA test called methylation analysis can confirm or rule out PWS in approximately 99% of cases by detecting whether the paternal genes in the chromosome 15 region are properly activated. Additional genetic testing can then determine which specific mechanism (deletion, maternal disomy, or imprinting defect) is responsible, which matters for genetic counseling about recurrence risk in future pregnancies.
Early diagnosis is important because it allows families to begin calorie monitoring and growth hormone therapy before obesity becomes established, ideally around 18 to 36 months of age.
Managing Daily Life With PWS
There is no cure for PWS, and no medication currently eliminates the hyperphagia. Management centers on strict dietary control and environmental strategies to prevent overeating. An energy-restricted but balanced diet, typically starting around age 2, aims for about 30% fat, 45% carbohydrates, 25% protein, and at least 20 grams of fiber daily. Portion sizes are carefully calibrated to the individual’s activity level and weight goals.
For many families, physical barriers to food access become necessary. Locking pantries, refrigerators, and kitchen cabinets is a common strategy when food-seeking behavior is evident. While these measures can feel extreme, they actually reduce anxiety for many people with PWS. Knowing that food is secured and not available for impulsive eating removes a constant source of temptation and distress. Regular weighing and financial restrictions (to prevent purchasing food independently) are additional tools families use.
Beyond diet, people with PWS benefit from consistent routines, structured physical activity to build muscle tone and burn calories, speech and occupational therapy in childhood, and behavioral support for compulsive tendencies and emotional regulation. Educational programs tailored to mild or moderate intellectual disability help children reach their developmental potential.
Life Expectancy and Health Risks
The primary threat to longevity in PWS is obesity and its complications. In adults, the leading causes of death are cardiovascular disease, respiratory failure, diabetes, sleep apnea, and hypertension, all closely tied to excess weight. One long-term study of 36 adults with genetically confirmed PWS found that 28% died over a 10-year follow-up period. Annual mortality for people with PWS is estimated at roughly 3%, compared to about 1% in the general population.
In children, the risk profile looks different. Childhood deaths are more often sudden and associated with respiratory infections or temperature regulation problems rather than obesity. With early diagnosis, growth hormone therapy, strict dietary management, and proactive medical care, many people with PWS now live well into adulthood. The condition requires lifelong supervision, but outcomes have improved substantially as awareness and treatment approaches have advanced.